TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24947928

Group type: EXPERIMENTAL
Intervention: Cetuximab
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Cisplatin plus cetuximab
Number of subjects: 45

Group type: COMPARATOR
Intervention: Cisplatin
Number of subjects: 45

Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 45

Group type: COMPARATOR
Intervention: Untreated
Number of subjects: 45
Study: 23301240

Group type: EXPERIMENTAL
Intervention: Herbal toothpaste (Himalaya Herbal Healthcare)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fluoridated toothpaste (Colgate Dental Cream)
Number of subjects: 60
Study: 19836169

Group type: EXPERIMENTAL
Intervention: Donepezil (5mg daily for 3 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18202212

Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 10 Hz rTMS
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 25 Hz rTMS
Number of subjects: 66

Group type: COMPARATOR
Intervention: Sham rTMS (occipital, 1 Hz)
Number of subjects: 66
Study: 16417782

Group type: EXPERIMENTAL
Intervention: Osteoking (25 ml every other day for 10 days)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Sanchi‐dansheng tablets (3 tablets thrice a day for 10 days)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Osteoking
Number of subjects: 62

Group type: COMPARATOR
Intervention: Sanchi‐dansheng tablets
Number of subjects: 62
Study: 11575540

Group type: EXPERIMENTAL
Intervention: Ephedrine (2 mg/min) plus phenylephrine (10 microg/min)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Ephedrine (2 mg/min) alone
Number of subjects: 39
Study: 9663418

Group type: COMPARATOR
Intervention: 3 x 100 mg alizapride plus placebo (group A)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 3 x 100 mg alizapride plus 3 x 4 mg dexamethasone (group B)
Number of subjects: 96
Study: 8176255

Group type: EXPERIMENTAL
Intervention: Topical 0.05% betamethasone dipropionate applied at 1600 h for 2 or 6 hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical 0.05% betamethasone dipropionate
Number of subjects: 0
Study: 3276238

Group type: EXPERIMENTAL
Intervention: Morphine 0.1 mg/kg IV
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 2285605

Group type: EXPERIMENTAL
Intervention: Anandron (300 mg) + orchiectomy
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo + orchiectomy
Number of subjects: 125
Study: 773413

Group type: EXPERIMENTAL
Intervention: 0.1% betamethasone valerate (BV)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 0.05% clobetasol propionate (CP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo preparations
Number of subjects: 20
Study: 30813767

Group type: EXPERIMENTAL
Intervention: Face-to-face and booklet (F2FB)
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: DVD and booklet (DVDB)
Number of subjects: 393

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 393
Study: 28864922

Group type: EXPERIMENTAL
Intervention: ABP 215
Number of subjects: 202

Group type: COMPARATOR
Intervention: Bevacizumab (US)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Bevacizumab (EU)
Number of subjects: 202
Study: 25251166

Group type: EXPERIMENTAL
Intervention: 12-session 12-month sweetened beverages decrease intervention or comprehensive dietary and physical activity intervention
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Beverage only intervention
Number of subjects: 172

Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 172
Study: 23956024

Group type: EXPERIMENTAL
Intervention: SMS text messaging intervention
Number of subjects: 755

Group type: COMPARATOR
Intervention: Assessment-only control group
Number of subjects: 755
Study: 20665554

Group type: EXPERIMENTAL
Intervention: Direct screening (invitation by letter followed by a home visit to administer the GDS-15)
Number of subjects: 10681

Group type: COMPARATOR
Intervention: Stepped screening (GDS-15 sent by post, home visit if score ≥4)
Number of subjects: 10681

Group type: EXPERIMENTAL
Intervention: Direct screening
Number of subjects: 10681

Group type: COMPARATOR
Intervention: Stepped screening
Number of subjects: 10681
Study: 19644132

Group type: EXPERIMENTAL
Intervention: Daily oral nutritional supplement containing 1.3 mg of riboflavin for 6 weeks
Number of subjects: 297

Group type: COMPARATOR
Intervention: Placebo for 6 weeks
Number of subjects: 297
Study: 17442999

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with vinorelbine and cisplatin
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Vinorelbine
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Cisplatin
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (vinorelbine and cisplatin)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Nonmalignant causes of death
Number of subjects: 155
Study: 15036680

Group type: EXPERIMENTAL
Intervention: Tadalafil 10mg (can be increased to 20mg or decreased to 5mg)
Number of subjects: 1173
Study: 11331444

Group type: EXPERIMENTAL
Intervention: Laparoscopic transabdominal preperitoneal mesh hernia repair (TAPP) and laparoscopic cholecystectomy (LC)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Open tension-free hernia repair and laparoscopic cholecystectomy (LC)
Number of subjects: 64
Study: 9487208

Group type: EXPERIMENTAL
Intervention: 35-picosecond pulses from neodymium:YAG laser
Number of subjects: 16

Group type: COMPARATOR
Intervention: 10-nanosecond pulses from neodymium:YAG laser
Number of subjects: 16
Study: 7945998

Group type: EXPERIMENTAL
Intervention: GnRH agonists
Number of subjects: 0

Group type: COMPARATOR
Intervention: danazol
Number of subjects: 0
Study: 2740299

Group type: EXPERIMENTAL
Intervention: School and community-based program for prevention of cigarette, alcohol, and marijuana use
Number of subjects: 4664

Group type: COMPARATOR
Intervention: Health education as usual
Number of subjects: 4664
Study: 31103370

Group type: EXPERIMENTAL
Intervention: Low-FODMAP diet
Number of subjects: 78

Group type: COMPARATOR
Intervention: mNICE diet
Number of subjects: 78
Study: 31034245

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 949

Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 949

Group type: EXPERIMENTAL
Intervention: Inadequate pain management
Number of subjects: 949

Group type: EXPERIMENTAL
Intervention: Inadequate sedation management
Number of subjects: 949
Study: 28728183

Group type: EXPERIMENTAL
Intervention: Early focal laser photocoagulation
Number of subjects: 58

Group type: COMPARATOR
Intervention: Sham laser
Number of subjects: 58
Study: 26177937

Group type: EXPERIMENTAL
Intervention: Olodaterol 2.5 μg BID
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Olodaterol 5 μg QD
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Olodaterol 5 μg BID
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Olodaterol 10 μg QD
Number of subjects: 206

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Olodaterol 5 μg QD vs Olodaterol 2.5 μg BID
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Olodaterol 10 μg QD vs Olodaterol 5 μg BID
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Morning and evening peak expiratory flow, Asthma Control Questionnaire scores
Number of subjects: 206
Study: 23500245

Group type: EXPERIMENTAL
Intervention: Aggressive medical therapy alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aggressive medical therapy with prompt revascularization
Number of subjects: 0
Study: 21690555

Group type: EXPERIMENTAL
Intervention: High-dose cytarabine (HDAraC)
Number of subjects: 459

Group type: COMPARATOR
Intervention: Timed-sequential chemotherapy (TSC)
Number of subjects: 459
Study: 19428033

Group type: EXPERIMENTAL
Intervention: Normal-fed condition
Number of subjects: 7

Group type: COMPARATOR
Intervention: 67-hour water-only fast
Number of subjects: 7
Study: 16394691

Group type: EXPERIMENTAL
Intervention: Plastic single-use laryngoscope blades
Number of subjects: 284

Group type: COMPARATOR
Intervention: Metal reusable laryngoscope blades
Number of subjects: 284
Study: 15245344

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 884

Group type: COMPARATOR
Intervention: Implantable cardioverter defibrillator (ICD) therapy
Number of subjects: 884
Study: 11993024

Group type: EXPERIMENTAL
Intervention: Intrathecal pethidine
Number of subjects: 90

Group type: COMPARATOR
Intervention: Hyperbaric Bupivacaine
Number of subjects: 90
Study: 8994413

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham smoking
Number of subjects: 40
Study: 8192452

Group type: EXPERIMENTAL
Intervention: Norfloxacin with sucralfate (1 g)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ofloxacin with sucralfate (1 g)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Norfloxacin or ofloxacin given 2 h before sucralfate
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Cumulative recovery of norfloxacin in urine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Cumulative recovery of ofloxacin in urine
Number of subjects: 8
Study: 3074277

Group type: EXPERIMENTAL
Intervention: Silymarin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Amino-imidazole-carboxamide-phosphate
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 29497177

Group type: EXPERIMENTAL
Intervention: Intermittent negative pressure (INP) + standard wound care (SWC)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Standard wound care (SWC) alone
Number of subjects: 9
Study: 27178479

Group type: EXPERIMENTAL
Intervention: Platelet transfusion with standard care
Number of subjects: 190

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 190
Study: 25503585

Group type: EXPERIMENTAL
Intervention: Erythropoiesis-stimulating agents (ESAs)
Number of subjects: 3405
Study: 22429513

Group type: EXPERIMENTAL
Intervention: Coblation adenotonsillectomy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Dissection adenotonsillectomy
Number of subjects: 100
Study: 19497032

Group type: EXPERIMENTAL
Intervention: Supervised stretch sessions for hamstring muscles, 30 min, five times a week for 6 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no stretch sessions)
Number of subjects: 60
Study: 18566197

Group type: EXPERIMENTAL
Intervention: Thoracic epidural anesthesia (TEA) with 0.75% ropivacaine intraoperatively and 0.2% ropivacaine postoperatively for 48 hours
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Thoracic epidural anesthesia (TEA)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (patient-controlled analgesia morphine)
Number of subjects: 50
Study: 15788122

Group type: EXPERIMENTAL
Intervention: Protein group (30 g/d protein)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 113
Study: 11954675

Group type: EXPERIMENTAL
Intervention: Experimental medication
Number of subjects: 0
Study: 10081516

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 265

Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 265
Study: 8626174

Group type: EXPERIMENTAL
Intervention: Salinum
Number of subjects: 20

Group type: COMPARATOR
Intervention: MAS‐84
Number of subjects: 20
Study: 2215987

Group type: EXPERIMENTAL
Intervention: Propofol injection for induction of anesthesia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continuous infusion of Diprivan (Propofol) for maintenance of anesthesia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Thiopentone combined with enflurane
Number of subjects: 0
Study: 398350

Group type: EXPERIMENTAL
Intervention: lofepramine
Number of subjects: 30

Group type: COMPARATOR
Intervention: mianserin
Number of subjects: 30
Study: 31935754

Group type: EXPERIMENTAL
Intervention: FDG PET/CT after radiochemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PET/CT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PET/MRI
Number of subjects: 0
Study: 31087325

Group type: EXPERIMENTAL
Intervention: 200 mg of micronized vaginal progesterone once daily from 16-26 weeks until 36 weeks of gestation
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo once daily from 16-26 weeks until 36 weeks of gestation
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: 200 mg of micronized vaginal progesterone once daily
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo once daily
Number of subjects: 109
Study: 27715351

Group type: EXPERIMENTAL
Intervention: Yeast β-glucan 477 mg/capsule
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 27056418

Group type: EXPERIMENTAL
Intervention: 7-day MAP treatment
Number of subjects: 45

Group type: COMPARATOR
Intervention: 14-day MAP treatment
Number of subjects: 45
Study: 24372492

Group type: EXPERIMENTAL
Intervention: Intensified enforcement
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Harsh jail penalty
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Immediate long license suspension
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Alternative ways to get home
Number of subjects: 121

Group type: COMPARATOR
Intervention: Delayed punishment due to judicial processing
Number of subjects: 121

Group type: COMPARATOR
Intervention: Fine penalty
Number of subjects: 121

Group type: COMPARATOR
Intervention: Legal blood alcohol concentration (BAC) limit
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Expecting a jail penalty for a DUI offense
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Previous experience of driving after drinking
Number of subjects: 121
Study: 22353899

Group type: EXPERIMENTAL
Intervention: Combined pre‐ and retro‐auricular incision
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard bayonet‐shaped incision
Number of subjects: 30
Study: 20373200

Group type: EXPERIMENTAL
Intervention: Motor imagery with visual, kinaesthetic, or visuo‐kinaesthetic imagery (15 and 150 trials)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group with no imagery
Number of subjects: 0
Study: 18983730

Group type: EXPERIMENTAL
Intervention: Comprehensive cohort studies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomized controlled trials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Practice-based studies
Number of subjects: 0
Study: 15965164

Group type: EXPERIMENTAL
Intervention: Goldmann applanation tonometer (GAT)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: GAT vs Tono-Pen XL
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: GAT vs ocular blood flow tonograph (OBF)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: GAT vs Canon TX-10 non-contact tonometer (NCT)
Number of subjects: 105

Group type: COMPARATOR
Intervention: GAT observers
Number of subjects: 105

Group type: COMPARATOR
Intervention: GAT vs Tono-Pen
Number of subjects: 105

Group type: COMPARATOR
Intervention: GAT vs OBF
Number of subjects: 105

Group type: COMPARATOR
Intervention: GAT vs NCT
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: GAT
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Tono-Pen
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: OBF
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: NCT
Number of subjects: 105
Study: 12057882

Group type: EXPERIMENTAL
Intervention: Dental amalgam restorations
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Multiple outcomes
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Interim comparisons
Number of subjects: 507
Study: 10489948

Group type: EXPERIMENTAL
Intervention: Immunohistochemistry (single section with two anticytokeratins AE‐1 and CAM 5.2)
Number of subjects: 736

Group type: COMPARATOR
Intervention: Serial sectioning and haematoxylin and eosin (two sections from each of six levels)
Number of subjects: 736

Group type: EXPERIMENTAL
Intervention: Immunohistochemistry
Number of subjects: 736

Group type: EXPERIMENTAL
Intervention: Immunohistochemically detected occult lymph-node metastases
Number of subjects: 736
Study: 8954303

Group type: EXPERIMENTAL
Intervention: Denial of hemiplegia patients
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (patients with neglect)
Number of subjects: 20
Study: 1492865

Group type: EXPERIMENTAL
Intervention: Dihydroergocristine (DHEC)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 3898010

Group type: EXPERIMENTAL
Intervention: Theophylline (10 mg/kg for 2-6 months, 12 mg/kg for 6-12 months, 16 mg/kg for 12-24 months)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 30481681

Group type: EXPERIMENTAL
Intervention: Exposure with elimination of safety behaviors (E/ESB)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Exposure with judiciously used safety behaviors (E/JU)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Both E/ESB and E/JU
Number of subjects: 60
Study: 29793828

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Low-dose transdermal testosterone gel (1.62%, 1.25 g)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Full replacement dose testosterone gel (1.62%, 5 g)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Full replacement dose testosterone gel with aromatase inhibitor
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Medical castration
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Change in serum 17β-estradiol concentration
Number of subjects: 53
Study: 27322115

Group type: EXPERIMENTAL
Intervention: Attention training condition with gaze-contingent feedback
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 36
Study: 23291316

Group type: EXPERIMENTAL
Intervention: Decision aid intervention in facilities with part-time NP/PA staffing
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Decision aid intervention in facilities with no NP/PA staffing
Number of subjects: 256

Group type: COMPARATOR
Intervention: Full-time NP/PA staffing
Number of subjects: 256
Study: 24573122

Group type: EXPERIMENTAL
Intervention: Vitamins (ascorbic acid and α‐tocopherol)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: n‐3 polyunsaturated fatty acids (eicosapentaenoic acid and docosahexaenoic acid)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Combination of vitamins and n‐3 PUFAs
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 75

Group type: COMPARATOR
Intervention: n‐3 PUFAs group
Number of subjects: 75
Study: 22499570

Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg·kg⁻¹)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 19690659

Group type: EXPERIMENTAL
Intervention: Calcaneal dual energy X-ray laser measurements
Number of subjects: 2884

Group type: EXPERIMENTAL
Intervention: Calcaneal dual energy X-ray laser T-score
Number of subjects: 2884

Group type: EXPERIMENTAL
Intervention: Calcaneal DXL and DXA T-scores
Number of subjects: 2884

Group type: EXPERIMENTAL
Intervention: Calcaneal DXL and DXA Z-scores
Number of subjects: 2884
Study: 17333971

Group type: EXPERIMENTAL
Intervention: 81 mg of acetylsalicylic acid (aspirin) ingested 24 hours before blood donation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no aspirin)
Number of subjects: 20
Study: 15273633

Group type: EXPERIMENTAL
Intervention: Continuous infusion of furosemide
Number of subjects: 22

Group type: COMPARATOR
Intervention: Intermittent bolus of furosemide
Number of subjects: 22
Study: 11575417

Group type: EXPERIMENTAL
Intervention: remifentanil 0.5 microg kg(‐1) followed by an infusion of 0.1 microg kg min(‐1)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: alfentanil 10 microg kg(‐1) followed by an infusion of saline
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 40
Study: 9827341

Group type: EXPERIMENTAL
Intervention: Hands-on booster
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Video booster
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study: 8596961

Group type: EXPERIMENTAL
Intervention: Metsan (Snowchem) and benzylbenzoate
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Mattress covers (Allergy Control Products)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study: 1961221

Group type: EXPERIMENTAL
Intervention: Oxygen plus continuous positive airway pressure
Number of subjects: 39

Group type: COMPARATOR
Intervention: Oxygen alone
Number of subjects: 39
Study: 7181051

Group type: EXPERIMENTAL
Intervention: 2-component extract (timothy major allergens Nos. 19 and 25)
Number of subjects: 100

Group type: COMPARATOR
Intervention: 20-component timothy extract
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 2-component extract
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: High single dose (greater than or equal to 1,000 biological units)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: High nasal sensitivity before treatment
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Immediate local skin reactions (greater than or equal to 2 cm)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Delayed local side effects (greater than or equal to 10 cm)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Delayed local side effects
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Repetition of a single dose
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Single doses (greater than or equal to 5,000 biological units)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Initial preseasonal therapy
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Subsequent perennial dosage
Number of subjects: 100
Study: 30340060

Group type: EXPERIMENTAL
Intervention: Patient plus partner (P+P)
Number of subjects: 301
Study: 27215634

Group type: COMPARATOR
Intervention: Moderate-intensity aerobic training (55% V˙O2 peak)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High-intensity aerobic training (75% V˙O2 peak)
Number of subjects: 12
Study: 25534777

Group type: EXPERIMENTAL
Intervention: Operant Conditioning (OC)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Systematic Desensitization (SysD)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Combined data from OC and SysD
Number of subjects: 68
Study: 24346489

Group type: EXPERIMENTAL
Intervention: Young women (45 years or younger)
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Older women (65 years or older)
Number of subjects: 243

Group type: COMPARATOR
Intervention: All age groups
Number of subjects: 243
Study: 22563189

Group type: EXPERIMENTAL
Intervention: AHM (0.15 gm/d) for 12 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (starch) for 12 weeks
Number of subjects: 40